Worth Asset Management LLC Acquires 51 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Worth Asset Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 750 shares of the healthcare conglomerate’s stock after acquiring an additional 51 shares during the quarter. Worth Asset Management LLC’s holdings in UnitedHealth Group were worth $360,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Apeiron RIA LLC lifted its holdings in shares of UnitedHealth Group by 0.8% in the first quarter. Apeiron RIA LLC now owns 2,581 shares of the healthcare conglomerate’s stock worth $1,222,000 after buying an additional 20 shares in the last quarter. Signet Financial Management LLC lifted its holdings in shares of UnitedHealth Group by 2.2% in the first quarter. Signet Financial Management LLC now owns 964 shares of the healthcare conglomerate’s stock worth $491,000 after buying an additional 21 shares in the last quarter. Financial Partners Group Inc raised its stake in UnitedHealth Group by 4.3% in the fourth quarter. Financial Partners Group Inc now owns 509 shares of the healthcare conglomerate’s stock valued at $252,000 after purchasing an additional 21 shares in the last quarter. Platform Technology Partners raised its stake in UnitedHealth Group by 0.7% in the first quarter. Platform Technology Partners now owns 3,251 shares of the healthcare conglomerate’s stock valued at $1,536,000 after purchasing an additional 21 shares in the last quarter. Finally, Carmichael Hill & Associates Inc. raised its stake in UnitedHealth Group by 11.4% in the first quarter. Carmichael Hill & Associates Inc. now owns 206 shares of the healthcare conglomerate’s stock valued at $97,000 after purchasing an additional 21 shares in the last quarter. Institutional investors own 85.69% of the company’s stock.

Insider Buying and Selling

In related news, CEO Andrew Witty sold 4,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the sale, the chief executive officer now directly owns 78,573 shares in the company, valued at approximately $39,772,866.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.35% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on UNH shares. Truist Financial lowered their target price on shares of UnitedHealth Group from $610.00 to $580.00 in a research note on Wednesday, June 14th. Mizuho reduced their price target on shares of UnitedHealth Group from $600.00 to $549.00 in a research report on Tuesday, July 11th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $527.00 to $532.00 and gave the company an “overweight” rating in a research report on Monday, July 17th. Stephens reiterated an “overweight” rating and set a $560.00 price target on shares of UnitedHealth Group in a research report on Friday, August 11th. Finally, UBS Group raised their target price on shares of UnitedHealth Group from $510.00 to $520.00 and gave the stock a “neutral” rating in a report on Wednesday, July 19th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $575.65.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $486.06 on Tuesday. The business has a fifty day simple moving average of $492.05 and a two-hundred day simple moving average of $486.73. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $450.24 billion, a P/E ratio of 21.75, a P/E/G ratio of 1.43 and a beta of 0.66. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $558.10.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.92 by $0.22. The firm had revenue of $92.90 billion during the quarter, compared to analyst estimates of $90.97 billion. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. UnitedHealth Group’s quarterly revenue was up 15.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.57 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 24.83 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be issued a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 annualized dividend and a yield of 1.55%. UnitedHealth Group’s payout ratio is 33.65%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.